J. Shelmet

Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance.

R. Hoeldtke, O. Owen, G. Reichard, 1988, The Journal of clinical investigation.

A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus.

S. Schwartz, R. Weinstein, D. Hassman, 2004, Clinical therapeutics.

Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes.

Y. Fujita-Yamaguchi, L. Tappy, O. Owen, 1988, The Journal of clinical investigation.

Effects of Anti-Insulin Receptor Antibodies (AIRA) on Downregulation and Turnover of Insulin Receptors on Cultured Hepatocytes

G. Boden, J. Shelmet, R. Shimoyama, 1986, Diabetes.

Patient Perception and Use of an Insulin Injector/Glucose Monitor Combined Device

B. Bode, S. Schneider, S. Skovlund, 2004, The Diabetes educator.

Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.

O. Owen, G. Boden, J. Shelmet, 1986, The New England journal of medicine.

Preference and resource utilization in elderly patients: InnoLet versus vial/syringe.

S. Skovlund, S. Schwartz, G. Peterson, 2004, Diabetes research and clinical practice.